Tumor microvascularity has no independent prognostic significance for breast cancer

Pathology

Volumn 30, Issue 2, 1998, Pages 105-110

  Mayers, Mavis M ^a   Seshadri, Ram ^a,c   Raymond, Wendy ^a   Mccaul, Kieran ^b   Horsfall, David J ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b South Australian Health Commission   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Angiogenesis; Breast cancer; Microvascularity; Prognosis

Indexed keywords

CD31 ANTIGEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; COHORT ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROGNOSIS; TUMOR VASCULARIZATION;

EID: 0031923925     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029800169046     Document Type: Article

References (16)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-6.
2. Folkman J, Klaasbrun M. Angiogenic factors. Science 1987; 235: 442-7.
3. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool. J Clin Oncol 1995; 13: 765-82.
4. Weidner N, Semple P, Welch W, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
5. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993; 55: 371-1.
6. Horak ER, Harris AL, Stuart N, Bicknell R. Angiogenesis in breast cancer. Regulation, prognostic aspects and implications for novel treatment strategies. Ann NY Acad Sci 1993; 698: 71-84.
7. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL. Tumor angiogenesis in node-negative breast carcinomas-relationship with epidermal growth factor receptor, estrogen receptor and survival. Breast Cancer Res Treat 1994; 29: 109-16.
8. Craft PS, Harris AL. Clinical prognostic significance of tumor angiogenesis. Ann Oncol 1994; 5: 305-11.
9. Ellis LM, Fidler IJ. Angiogenesis and breast cancer metastasis. Lancet 1995; 12: 388-90.
10. Hayes DF. Angiogenesis and breast cancer. Haematol Oncol Clinics N A 1994; 8: 51-71.
11. Vermeulen PB, Libura J, Libura M, Hellemans PWJ, Van Marck E, Van Oosterom AT et al. Correspondence. Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. JNCI 1995; 23: 1797-803.
12. Axelsson K, Ljung B-ME, Moore II DH, Thor AD, Chew KL, Edgerton SM et al. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. JNCI 1995; 87: 997-1008.
13. Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR, Hellman S. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. JNCI 1996; 88: 1764-9.
14. Walker R A. Angiogenesis and breast cancer prognosis - a continuing issue (editorial). J Pathol. 1996; 180: 6-7.
15. Weidner N. Angiogenesis in breast cancer. Cancer Treat Res 1996; 83: 265-301.
16. Toi M, Kondo S, Suzuki H, Yamamoto Y, Inada K, Imazawa T et al. Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer 1996; 77: 1101-6.